Position in NVCR
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$935,770
+$545,136 QoQ
Shares Held
61,767
+72.4% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 15 holders
Holding Since
Jun 2021
5 quarters on record
Voting authority
Sole 8.423591885634723.ToString("F0")%
Shared 0.ToString("F0")%
None 91.57640811436526.ToString("F0")%
Common Shares in NVCR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $284,979,146 across 56 Medical Devices names. NVCR ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
1,164,059 | $105,626,713 | |
| 2 | MDT |
Medtronic plc
|
921,461 | $72,085,894 | |
| 3 | SYK |
Stryker Corp
|
135,035 | $42,514,419 | |
| 4 | BSX |
Boston Scientific Corp
|
249,780 | $10,660,610 | |
| 5 | EW |
Edwards Lifesciences Corp
|
89,705 | $8,114,714 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
74,825 | $6,441,684 | |
| 7 | STE |
STERIS plc
|
28,195 | $5,937,021 | |
| 8 | DXCM |
Dexcom Inc
|
77,644 | $5,229,323 |
All Filings in NVCR
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $935,770 | 61,767 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $390,634 | 35,838 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $338,959 | 26,215 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $143,618 | 11,116 | Shares | Sole | 2025-10-29 | |
| 2021-06-30 | $1,752,378 | 7,900 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||